What You Need To Know About The New Libido Pill For Women
By: Elizabeth Palermo Published: 08/21/2015 10:58 AM EDT on LiveScience Some health professionals are reacting with more enthusiasm than others about the first approved drug aimed at increasing women's sexual desire. Known generically as flibanserin and sold under the brand name Addyi, the medication could be prescribed as early as Oct.17, said Sprout Pharmaceuticals, the company that developed the so-called "little pink pill." Many have compared Addyi to Viagra, the medication for men with erectile dysfunction that increases blood flow to the penis. But the new pill for women aims to boost women's libidos by affecting lev...
Source: Science - The Huffington Post - August 24, 2015 Category: Science Source Type: news
Next for Addyi drugmaker: Eliminating the stigma over low female sex drive
Sprout Pharmaceuticals CEO Cindy Whitehead isn't in the business of treating mental illness. Her company's drug, Addyi, was approved this week by the FDA to treat low sexual desire in women, also known as hypoactive sexual dysfunction disorder, or HSDD.
But she finds herself thinking about early conversations around mental illness quite a bit, in the context of all the conversations she's having around her drug and its intended use.
"There are a lot of parallels," she told me Thursday.
Both mental… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 21, 2015 Category: American Health Authors: Mary Johnson Source Type: news
It’s NOT a “pink Viagra”
Many of my patients, colleagues, friends, and even neighbors have asked me about the new drug flibanserin (brand name Addyi). Just this past Tuesday, the FDA approved this drug for treatment of low sexual desire in women. Flibanserin has generated more questions, comments, and media inquiries for me than I’ve ever experienced in my 20-year career as an Ob/Gyn. While there are several medications that improve sexual function in men (including Viagra, the most famous one), flibanserin is the first drug ever approved by the FDA to improve sexual function in women. Here are what I consider the relevant facts and data about f...
Source: New Harvard Health Information - August 21, 2015 Category: Consumer Health News Authors: Hope Ricciotti Tags: Drugs and Supplements Health female viagra flibanserin Source Type: news
1st Female Sexual Dysfunction Drug: What to Know Before Prescribing1st Female Sexual Dysfunction Drug: What to Know Before Prescribing
Dr Andrew Kaunitz summarizes the issues you need to be aware of before prescribing flibanserin (Addyi). Medscape Ob/Gyn (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - August 20, 2015 Category: OBGYN Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news
'Female Viagra' gets FDA approval
Women who have lost their sex drive will have a little pink pill to help them come October. On Tuesday, the U.S. Food and Drug Administration approved flibanserin, which will be sold as Addyi, for the treatment of sexual dysfunction in premenopausal ... (Source: WDSU.com - Health)
Source: WDSU.com - Health - August 20, 2015 Category: Consumer Health News Source Type: news
Is Testosterone Treatment Safe And Effective?
Testosterone, the hormone most responsible for "maleness" in men, naturally declines with age. Drug companies have capitalized on this fact, and on the vague symptoms that make up the non-medical, popular term "andropause". Supposedly, low or even low-ish testosterone levels can make men feel bad---really, really bad. Symptoms attributed to this putative condition range from sexual dysfunction, to fatigue, mood changes, and irritability. Unfortunately, all of these symptoms are common and vague, making it difficult to find out if low testosterone is responsible for the symptoms. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 19, 2015 Category: Pharmaceuticals Authors: Peter Lipson Source Type: news
Sprout CEO on FDA's approval of women's sex drug Addyi
The FDA is giving the green light to flibanserin, the first prescription medication for women's sexual dysfunction (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 19, 2015 Category: Consumer Health News Source Type: news
Better treatments needed for female sexual dysfunction
Millions of women suffer from low libido, but even with new drug, they have very few options (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 19, 2015 Category: Consumer Health News Source Type: news
Sprout’s Addyi obtains FDA approval to treat sexual dysfunction in women
Sprout Pharmaceuticals has obtained approval from the US Food and Drug Administration (FDA) for its Addyi (flibanserin 100mg) to treat acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 18, 2015 Category: Pharmaceuticals Source Type: news
FDA Approves Women's Sex Pill Addyi With Safety Restrictions
WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men. But stringent safety measures on the daily pill called Addyi mean it will probably never achieve the sales of Viagra, which has generated billions of dollars since the late 1990s. The drug's label will bear a boxed warning — the most serious type — alerting doctors and patients to the risks of dangerously low blood pressure and fainting, especia...
Source: Science - The Huffington Post - August 18, 2015 Category: Science Source Type: news
The “Cuddle” Hormone Can Save Your Life
I’m delighted that John Gray, the author of international bestseller Men Are from Mars, Women Are from Venus, will be speaking at my 2015 Palm Beach Anti-Aging Summit in October.
I’m especially pleased he’s going to be talking about the dangers of stress and how it’s on the rise for both men and women – but especially women.
I’ve been talking to my patients about the dangers of stress for years – because, if left unchecked, stress will sabotage your immune system and accelerate aging.
John even tells me that on average women are four times more stressed than men.
But the problem for men an...
Source: Al Sears, MD Natural Remedies - August 7, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Brain Health hormones Source Type: news
If you purchase an embarrassing product online, do you still blush? New study says yes
Published research and common knowledge suggest that embarrassment is something we experience only when we are around other people. But a new research study has found that people often are embarrassed when buying sensitive health care products privately and online -- products such as home test kits and medications for incontinence and sexual dysfunction. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 6, 2015 Category: Science Source Type: news
If you purchase an embarrassing product online, do you still blush? New study says yes
(Indiana University) Published research and common knowledge suggest that embarrassment is something we experience only when we are around other people. But a new research study co-authored by an Indiana University professor found that people often are embarrassed when buying sensitive health care products privately and online -- products such as home test kits and medications for incontinence and sexual dysfunction. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 6, 2015 Category: Global & Universal Source Type: news
Drop in numbers of men relying on sexual dysfunction drugs
Over €57m spent by health authority on prescription drugs like Viagra since 2009 (Source: The Irish Times - Health)
Source: The Irish Times - Health - July 5, 2015 Category: Consumer Health News Source Type: news
Novel Drug Promising for Sexual Dysfunction in WomenNovel Drug Promising for Sexual Dysfunction in Women
Novel melanocortin-receptor-4 agonist, bremelanotide, appears to be effective in treating women with hypoactive sexual desire disorder or sexual arousal disorder. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 29, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news
